- Home
- BFRI vs AEON Comparison
BFRI vs AEON Comparison
Compare BFRI & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- AEON
- Stock Information
- Founded
- BFRI 1997
- AEON N/A
- Country
- BFRI United States
- AEON United States
- Employees
- BFRI N/A
- AEON N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- BFRI Health Care
- AEON Health Care
- Exchange
- BFRI Nasdaq
- AEON Nasdaq
- Market Cap
- BFRI 7.5M
- AEON 8.0M
- IPO Year
- BFRI 2021
- AEON N/A
- Fundamental
- Price
- BFRI $0.70
- AEON $0.84
- Analyst Decision
- BFRI Strong Buy
- AEON Strong Buy
- Analyst Count
- BFRI 1
- AEON 1
- Target Price
- BFRI $2.75
- AEON $360.00
- AVG Volume (30 Days)
- BFRI 175.2K
- AEON 402.3K
- Earning Date
- BFRI 08-13-2025
- AEON 08-11-2025
- Dividend Yield
- BFRI N/A
- AEON N/A
- EPS Growth
- BFRI N/A
- AEON N/A
- EPS
- BFRI N/A
- AEON 117.22
- Revenue
- BFRI $37,997,000.00
- AEON N/A
- Revenue This Year
- BFRI $11.75
- AEON N/A
- Revenue Next Year
- BFRI $17.09
- AEON N/A
- P/E Ratio
- BFRI N/A
- AEON $0.01
- Revenue Growth
- BFRI 14.28
- AEON N/A
- 52 Week Low
- BFRI $0.54
- AEON $0.38
- 52 Week High
- BFRI $2.22
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- BFRI 57.11
- AEON 60.41
- Support Level
- BFRI $0.59
- AEON $0.73
- Resistance Level
- BFRI $0.73
- AEON $0.81
- Average True Range (ATR)
- BFRI 0.05
- AEON 0.08
- MACD
- BFRI 0.01
- AEON -0.00
- Stochastic Oscillator
- BFRI 66.46
- AEON 53.38
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.